Zoom Webinar: https://bit.ly/3r5stWH
MR metabolic imaging of neurological disorders
Since 2003, hyperpolarized (HP) 13C has been revolutionizing the field of cancer imaging. Through a >10-50,000 increase in the MR signal of 13C-labeled probes, this methodology can monitor metabolic reactions in real-time in vivo and improve the detection of neoplasms in preclinical models and in cancer patients. More recently, as metabolic impairment plays a crucial role in most brain diseases, HP 13C MR imaging has proven as a viable tool for imaging neurological disorders. In this webinar, Dr. Myriam Chaumeil will discuss emerging applications for HP-13C MRI in detecting and monitoring metabolic impairments and neuroinflammatory processes in preclinical models of brain diseases and will discuss future directions and potential for metabolic imaging to fill current clinical gaps.
Prof. Myriam CHAUMEIL
Associate Professor in Residence
Physical Therapy and Rehabilitation Science/Radiology & Biomedical Imaging
University of California San Francisco
More info: http://chaumeillab.ucsf.edu